Objectives/Hypothesis: The purpose of this study is to evaluate the outcomes and complications associated with early gold weight implantation for management of the paralyzed eyelid. Study Design: A retrospective review of clinical charts was conducted to analyze results and complications in patients who underwent gold weight implantation within 30 days of onset of facial nerve paralysis and to compare these outcomes with those of patients who received gold weights after a traditional waiting period. Methods: The charts of 67 patients who underwent gold weight implantation during the time period of this study were reviewed. Patients were categorized into "early" or "late" groups based on whether gold weights were implanted before or after 30 days following onset of facial nerve paralysis. Etiology of facial nerve paralysis, degree of paralysis, timing of surgery, and outcomes of the procedure, including degree of lid closure and complication rates, were compared between the two groups. Results: Of the 67 patients, 49.3% underwent gold weight implantation within 30 days of onset of paralysis and 50.7% received gold weights after 30 days. A total of 89.2% of all patients who underwent implantation in this study achieved satisfactory lid closure after the initial procedure. Both early and late implantation groups had statistically similar lid closure and complication rates. Conclusions: Implantation of gold weights within 30 days of paralysis is as effective for the management of paralytic lagophthalmos as delayed implantation and is not associated with higher complication rates. Early implantation of gold weights should be considered in all patients with paralytic lagophthalmos.
INTRODUCTION
Management of the eye is arguably one of the most important aspects in the treatment of the patient with facial nerve paralysis. The ocular manifestations of facial nerve paralysis include incomplete eye closure, paralytic ectropion, brow ptosis, decreased tear production, and loss of the corneal "squeegee effect." 1 Each of these factors contribute to inadequate corneal protection, which can result in exposure keratitis, corneal ulceration, and, ultimately, blindness.
The paralyzed eye can be conservatively managed with lubrication, moisture chambers, and lid taping, but these methods can be cumbersome and difficult for some patients and may provide suboptimal corneal protection. Options for surgical management of the paralyzed eyelid include a number of static and dynamic techniques, such as tarsorrhaphy, canthoplasty, temporalis muscle transfer, and implantation of lid springs and weights. Gold weight lid loading has been shown by multiple authors to be a safe, reproducible, and effective technique for rehabilitation of the paralyzed lid. [1] [2] [3] [4] [5] Weighting of the upper lid results in an increased gravitational pull on the lid, and with the relaxation of the levator palpebrae muscle that occurs with attempted eye closure, the eyelid passively closes.
Sheehan initially described upper lid loading in 1950, using folded tantalum gauze as an implant material. 6 Gold was first used as a lid load in 1966 7 and it has since become the material of choice because of its high density, relative inertness, and good color match for the skin of the upper lid. Traditionally, gold weight lid loading has been advocated as a technique for management of the paralyzed eyelid after a trial of conservative management has failed, and there is no evidence of return of facial nerve function. 1, 2 This waiting period is sometimes as long as 6 to 9 months after the onset of facial nerve paralysis. May et al. 8 eyelid only for patients who fail medical management or are known to have total and permanent paralysis. Medical management is recommended for patients who undergo nerve grafting when recovery is not expected for 6 to 12 months, and in patients with Bell's palsy who may not recover function for 6 weeks to 3 months. A recent trend toward earlier implantation of gold weights has been described in the literature; however, the outcomes of this technique have not been thoroughly investigated. 9 -13 We have adopted an aggressive approach to management of the paralyzed eyelid, which includes early gold weight implantation within the first 30 days of facial nerve paralysis. The purpose of this study is to evaluate the outcomes and complications associated with early gold weight implantation for facial nerve paralysis.
MATERIAL AND METHODS
Between May 1993 and June 2000, a total of 84 gold weights were surgically implanted in the upper lids of 72 patients for the treatment of paralytic lagophthalmos. A retrospective review of clinical charts was conducted to analyze results and complications of patients who underwent "early" gold weight implantation compared with patients who received gold weights after a traditional waiting period.
In this series, each gold weight was implanted by one of six surgeons in the Departments of Plastic Surgery and Otolaryngology-Head and Neck Surgery at the University of Nebraska Medical Center. Each patient was sized preoperatively for the appropriate weight using commercially available gold bars ranging in weight from 0.8 to 1.6 g (MedDev Corp., Los Altos, CA). A 1.0-g weight was initially selected and adhered to the lid with benzoin solution, and lid closure was assessed in both the upright and supine position. The weight was sized up or down as needed to achieve adequate closure without ptosis. Surgical procedures were performed under either local or general anesthesia. After placement of a corneal shield, a 1.5-cm incision was made in the supratarsal crease and carried through the orbicularis muscle to the tarsal plate. A pocket approximately the size of the implant was created in the retro-orbicular plane without skeletonizing the tarsal plate, staying at least 2 mm superior to the lid margin. The appropriate gold weight was placed in the pocket, centered just medial to the mid-pupillary position, and secured to the tarsus with two partial-thickness sutures of 6-0 clear polypropylene. The orbicularis muscle was closed over the implant with absorbable sutures and the skin reapproximated with a running suture of 6-0 nylon or fast-absorbing gut.
Following implantation, some patients experienced return of facial nerve function and underwent elective removal of gold weights in the clinic under local anesthesia. The previous incision was opened and carried down through the orbicularis to the gold weight. The weight was then removed from its pocket after cutting any remaining sutures and the skin was closed with a running suture of 6-0 fast-absorbing gut.
The clinical charts of all patients who underwent gold weight implantation during the time period of this study were reviewed. Relevant demographic and pre-and postoperative clinical data were collected, including the etiology of facial nerve paralysis, degree of paralysis, as graded by the HouseBrackmann scale, 14 timing of surgery, outcome, and complications. Patients were categorized into "early" or "late" groups based on timing of gold weight implantation. Early patients were those who underwent the procedure within 30 days of onset of facial nerve paralysis, and late patients were those who were implanted after this time period. Results were categorized by degree of eye closure: complete closure, partial closure with 1 to 3 mm of residual lagophthalmos, or incomplete closure (Ͼ3 mm lagophthalmos). Patients in whom only partial closure was achieved, with 1 to 3 mm residual lagophthalmos, had adequate corneal coverage and did not require any further intervention. During the review, all complications and any additional procedures, including revision or removal of the gold weight, were noted. The Wilcoxon's rank sum test was used to compare the early implant group with the late implant group based on age and weight of implant. Fisher's exact test was used to compare the two groups regarding patient gender, degree of facial paralysis, and results (degree of lid closure, complication rates, and number of implants removed). Tests were two-sided, and a significance level of 0.05 was chosen.
RESULTS
During the 7-year time period of the study, 72 patients underwent implantation of gold weights for treatment of paralytic lagophthalmos. Complete clinical data were unavailable for 5 patients; they were excluded from the study. Each of the remaining 67 patients experienced facial nerve paralysis secondary to a variety of etiologies (Table I ). The House-Brackmann scale 14 was used to preoperatively grade the degree of facial paralysis. Implants ranged in weight from 0.8 g to 1.6 g, with 1.2 g being the most commonly implanted size. Our study group included 38 males and 29 females with a mean age of 52.5 years (range, 8 -84 y). All 67 patients were evaluated postoperatively, with a mean follow-up of 13.0 months.
The time interval between onset of facial nerve paralysis and gold weight placement ranged from 0 days to 84 years. One patient with congenital facial nerve paralysis underwent implantation at 84 years of age. We identified 33 early patients (49.3%) who underwent gold weight implantation within 30 days of onset of paralysis, with a mean delay of 18.9 days. The late group consisted of 34 patients (50.7%) who received their gold weights after 30 days of onset of paralysis, with a mean delay of 66.2 months (range, 35 d to 84 y). The mean delay of this group was 35.3 months after excluding the 84-year-old patient with congenital paralysis. The patients in the early and late groups had similar characteristics, including age and gender, degree of facial paralysis, and weight of implant (Table II) .
The early group included 3 patients with normal preoperative facial nerve paralysis who received gold weights at time of facial nerve resection during parotidec- tomy. Another 15 patients underwent the procedure concomitantly with facial nerve decompression: 10 with the diagnosis of Bell's palsy, 4 with temporal bone trauma, and 1 with herpes zoster oticus. Eight patients underwent early gold weight implantation following facial nerve paralysis associated with resection of an acoustic neuroma. The degree of postoperative eye closure was recorded in the charts of 65 of the 67 patients. Forty-eight patients (73.8%) had complete eye closure, and 10 patients (15.4%) had closure within 1 to 3 mm, which provided adequate corneal coverage. Seven patients (10.8%) had incomplete closure with inadequate corneal protection. Three of these 7 patients underwent revision procedures with placement of heavier weights, resulting in complete closure in 2 patients and partial closure with adequate corneal coverage in the third. Three others were offered revision but declined, and the final patient experienced return of facial nerve function and underwent removal of the weight. In the "early" group, 69.7% of patients had complete closure postoperatively, 21.2% had adequate closure with 1 to 3 mm residual lagophthalmos, and 9.1% had incomplete closure. These results were not statistically different from those in the late group (Table III) . Overall, 89.2% of patients who underwent gold weight implantation in this study period achieved satisfactory lid closure and corneal protection following the initial procedure.
The overall complication rate was 22.4% (Table IV) . Extrusion of gold weights occurred in 6 patients, 4 of whom were operated on by one surgeon. After a modification of technique by this surgeon, no further extrusions were encountered. Two of the 6 patients underwent replacement with good closure postoperatively, 3 declined replacement, and 1 experienced return of facial nerve function. Four patients developed erythema and irritation of the upper lid following gold weight placement. One of these patients underwent removal and replacement of the weight, another was treated with antibiotics, and 2 experienced return of facial nerve function and underwent removal of the weights. Two patients had mild upper lid ptosis postoperatively but both declined revisions. Migration of the implant to an unfavorable lid position occurred in 3 patients, resulting in poor lid closure. Revision procedures were performed in all 3 patients and complete eye closure was achieved. The difference in complication rates between the early and late groups was not statistically significant (Table III) .
Eleven of the 33 patients (33.3%) in the early implantation group experienced return of facial nerve function during the 7-year time period of the study and underwent removal of their gold weights, compared with 9 of the 34 patients (26.5%) in the late group. This difference was not statistically significant (Table III) . In these 20 patients, gold weights were in place for an average of 9.9 months before removal (range, 1.8 -32.9 mo). All patients had normal upper lid function after removal and no complications were encountered.
DISCUSSION
The goal of rehabilitation of the paralyzed eyelid is protection of the cornea and preservation of vision. Various techniques to achieve this goal have been used, including tarsorrhaphy, temporalis muscle transfer, upper lid springs and weights. Tarsorrhaphy provides effective corneal protection, but it limits vision, is cosmetically unappealing, and can be difficult to reverse. Temporalis transfer often causes considerable distortion of the upper lid and often produces unnatural eye closure while eating. Additionally, eye closure is frequently incomplete at night because of relaxation of the temporalis muscle. The implanting of upper lid springs is technically challenging and is associated with high complication rates. 15 Gold weight implantation has been shown by multiple authors to be effective for the treatment of paralytic lagophthalmos and is considered by some to be the gold standard for management of the paralyzed eyelid. [1] [2] [3] [4] [5] A 1999 survey of North American otolaryngologists and ophthalmologists found that an upper eyelid weight was the procedure of choice for management of established paralytic lagopthalmos. 16 The advantages of gold weights have been well documented in the literature, including the simplicity of the procedure, low complication rate, and complete reversibility. [1] [2] [3] [4] [5] Traditionally, surgical reanimation of the paralyzed face is not initiated until an adequate "waiting period" has passed to allow for return of facial nerve function. 1, 2, 8 This is a wise approach when considering an irreversible procedure such as a unilateral brow lift or a cable graft of the facial nerve. However, the paralyzed eyelid presents a problem that demands immediate attention and, ideally, immediate rehabilitation. We think aggressive, early management of the paralyzed eyelid is warranted to avoid the potentially significant ocular sequelae. Greater than 90% of patients in this study who underwent implantation of gold weights within 30 days of onset of paralysis had adequate eye closure and corneal protection following the procedure. The rate of incomplete closure and the complication rate did not significantly differ between patients undergoing early implantation and those implanted after a traditional "waiting period."
There are many causes of facial nerve paralysis, and none are contraindications for gold weight implantation. We identified several groups of patients who are ideal candidates for immediate or early implantation, based on the etiology of paralysis: those with parotid neoplasms, Bell's palsy, or acoustic neuromas. Primary and metastatic parotid malignancies may cause preoperative facial paralysis by nerve invasion. Even with intact preoperative facial function, malignant and benign parotid tumors can involve the facial nerve, necessitating resection at the time of tumor removal. If the facial nerve is resected with removal of the tumor, these patients rarely, if ever, regain normal facial function postoperatively. Although the nerve can be reconstructed with a cable graft, facial function may take months or years to return. Early gold weight implantation should be considered in these situations.
Patients who undergo parotidectomy with preservation of the facial nerve may have partial or complete facial nerve paralysis postoperatively. Mehle et al. 17 noted a 46.1% incidence of immediate facial nerve dysfunction in patients who underwent parotidectomy with preservation of the nerve, but only 3.9% demonstrated long-term paralysis. In general, patients with postoperative facial nerve dysfunction following parotidectomy with preservation of the facial nerve are not considered candidates for early gold weight implantation, because the majority will recover.
Bell's palsy is responsible for approximately 50% of all cases of facial nerve paralysis, 18 and was the most common cause of paralytic lagophthalmos in our study. Eleven of the 15 patients diagnosed with Bell's palsy underwent placement of a gold weight at the time of facial nerve decompression. Nine of these patients were in the "early" group, and 5 of the 9 experienced return of facial nerve function and underwent removal of gold weights at a later date. Eighty-five percent patients with Bell's palsy spontaneously recover, and only a small number eventually undergo surgical decompression. Patients who undergo facial nerve decompression can benefit from concurrent gold weight implantation. Although up to 90% of patients eventually recover facial nerve function following decompression, it can take months for function to completely return. 19 While waiting for nerve recovery, the eye is protected, and after recovery occurs the weight can be removed.
Other patients to consider for early gold weight implantation are those undergoing acoustic neuroma resection, including those with normal preoperative facial function. Partial to complete facial paralysis following acoustic neuroma resection has been reported in recent years to range from 33% to 50%, even with a 94% to 95% rate of anatomic preservation of the nerve. 20, 21 A gold weight may be placed immediately in patients in whom the facial nerve is injured or sacrificed intraoperatively, regardless of the type of procedure. Preoperative sizing for the correct weight is not possible in unexpected nerve resections, because most of these patients have normal preoperative facial nerve function. In these cases, a 1.2-g weight is usually selected. Alternatively, a gold weight can be implanted in the early postoperative period, which allows sizing to accurately select the proper weight. When the facial nerve is repaired or a cable graft is placed, restoration of facial function can take months to years. Gold weights can be removed if facial nerve function returns. We have encountered no complications or postremoval sequelae in our 20 patients who underwent gold weight removal.
CONCLUSION
We found that implantation of gold weights within 30 days of paralysis is as effective for management of paralytic lagophthalmos as traditionally delayed procedures. In addition, early implantation is not associated with higher complication rates. Early implantation of gold weights should be considered in all patients with paralytic lagophthalmos.
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